Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program

Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program

Pharmacogenomic (PGx) evidence for selective serotonin reuptake inhibitors (SSRIs) continues to evolve. For sites offering testing, maintaining up-to-date interpretations and implementing new clinical decision support (CDS) driven by existing results creates practical and technical challenges. Vande...

Full description

Bibliographic Details
Main Authors: Michelle Liu, Sara L. Van Driest, Cindy L. Vnencak-Jones, Leigh Ann G. Saucier, Bartholomew P. Roland, Cheryl L. Gatto, Shari L. Just, Asli O. Weitkamp, Josh F. Peterson
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Personalized Medicine
Subjects:
pharmacogenomics
pharmacogenetics
personalized medicine
precision medicine
SSRIs
reprocessing
Online Access:https://www.mdpi.com/2075-4426/11/11/1051

Internet

https://www.mdpi.com/2075-4426/11/11/1051

Similar Items